Laahn Foster headshot
LF

Laahn H. Foster

Associate Professor
Unit: School of Medicine
Department: Department of Medicine, Hematology and Oncology
Office location and address
Emily Couric Clinical Cancer Center
1335 Lee St
Charlottesville, Virginia 22903
Education
New York Medical College, MD
Residency, University of Medicine and Dentistry of New Jersey
Fellowship, University of Virginia
MD-INMD-HO - Foster - Janssen MMY3019
Source: Janssen Research & Development, LLC
March 11, 2019 – December 31, 2025
A Randomized Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transpla
Source: Janssen Research & Development, LLC
September 23, 2019 – February 28, 2024
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended For Early Autologous Transplantation
Source: ECOG-ACRIN Cancer Research Group
February 05, 2021 – February 04, 2024
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Source: ECOG-ACRIN Cancer Research Group
March 25, 2020 – March 24, 2023
M20-917: Multiple Myeloma: Lemzoparlimab (TJ011133) as Monotherapy and in Combination with Anti-Myeloma Regimens in Subjects with Relapsed/Refractory Multiple Myeloma
Source: AbbVie Inc.
August 31, 2021 – August 30, 2022
A Multicenter Phase 2 Study to Evaluate Subcutaneous Daratumumab in Combination with Standard Multiple Myeloma Treatment Regimens
Source: Janssen Research & Development, LLC
July 06, 2018 – January 22, 2020